Atrial Fibrillation Risk With Cancer Drugs Underestimated

Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials, and so oncologists may underestimate the risk of this adverse event.
Medscape Medical News

source https://www.medscape.com/viewarticle/990547?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors